| Attributes | Values |
|---|
| rdf:type
| |
| description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в січні 1998 (uk)
- articolo scientifico (pubblicato il 1998) (it)
- im Januar 1998 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en xineru de 1998 (ast)
- scientific article published on 01 January 1998 (en)
- artikull shkencor i botuar më 01 janar 1998 (sq)
|
| publication date
| |
| publication date
| |
| exact match
| |
| exact match
| |
| author name string
| |
| author name string
| - Goldman JM
- Schmitz N
- Niethammer D
|
| rdfs:label
| - Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (en)
- Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (nl)
- Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (sq)
|
| skos:prefLabel
| - Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (en)
- Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (nl)
- Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (sq)
|
| name
| - Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (en)
- Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (nl)
- Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (sq)
|
| author
| |
| author
| |
| title
| |
| title
| - Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| |
| Dimensions Publication ID
| |
| Dimensions Publication ID
| |
| is about
of | |
| is cites work
of | - Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease
- Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.
- High-dose chemotherapy for solid tumors: results of the EBMT.
- Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
- Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe
- Stem cell transplantation
- Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience
- Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.
- High-dose chemotherapy for ovarian carcinoma: long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)
- The interface between assisted reproductive technologies and genetics: technical, social, ethical and legal issues.
- Intensive enteral nutrition support in paediatric bone marrow transplantation
- Bone marrow transplantation for beta-thalassaemia major: the UK experience in two paediatric centres.
- Hematopoietic stem cells: transcriptional regulation, ex vivo expansion and clinical application
- G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.
- The role of the EBMT activity survey in the management of hematopoietic stem cell transplantation. European Group for Blood Marrow Treansplantation.
- Treatment of multiple myeloma
- Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report
- A comparison of inpatient and outpatient ASCT.
- Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation
- Endocrine complications after hematopoietic stem cell transplantation during childhood and adolescence
- Quality-assessments of characteristics of placental/umbilical cord blood associated with maternal age- and parity-related factor
- Hematopoietic stem cell transplantation for beta-thalassemia major: experience in south of Iran
- Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019.
- Hematopoietic and immune recovery after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation in a pediatric population
- Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms.
- Can corporatization contribute to quality assurance and cost control in the German hospital sector? A pilot project for stem cell transplantation
- [Respiratory complications in hematopoietic stem cell transplantation. What does radiology contribute?]
- Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: experience of Ibni Sina Hospital
- Late effects of transplantation. Gerard Socie, for the Late Effects Working Party of the European Group for Blood and Marrow Transplantation
- Is endocrinological assessment and follow-up of children after bone marrow transplantation necessary? How, and for how long?
- Stem cell transplantation
|
| is cites work
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)